Nasdaq

Helius Medical Technologies Announces Positive Results from PoNS Stroke Registrational Program Supporting Planned FDA Submission for Gait and Balance Therapy

Helius Medical Technologies, Inc. announced positive outcomes from its Portable Neuromodulation Stimulator (PoNS) Stroke Registrational Program (SRP), which supports a planned FDA submission for ...
Nasdaq

Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation

NEWTOWN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and ...
Business Insider

Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple ...

--PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy on gait deficit improvement in people with Multiple Sclerosis-- --Statistically ...
Seeking Alpha

Helius Medical Technologies Announces Authorization from Health Canada to Market Portable Neuromodulation Stimulator (PoNS®) Device for the Treatment of Gait Deficit Due to ...

NEWTOWN, Pa., March 09, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (HSDT) (“Helius”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance ...
WebMD

Pons: What to Know

Your brainstem is the central apparatus of your entire nervous system. One portion of your brainstem is called the pons. The pons links your brain to your spinal cord. Your pons handles all of your ...